Trials / Sponsors / Repligen Corporation
Repligen Corporation
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression Bipolar I Depression | Phase 2 | 2008-11-01 |
| Completed | Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas Pancreatitis | Phase 3 | 2008-03-01 |
| Completed | Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression Bipolar Depression | Phase 2 | 2006-03-01 |
| Completed | Synthetic Human Secretin in Children With Autism Autism | Phase 3 | 2002-04-01 |
| Terminated | Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction Autism | Phase 3 | 2002-04-01 |
| Terminated | RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease Mitochondrial Diseases | Phase 1 | — |